Neighborhoods in highest quartile of structural racism had elevated cancer risk from traffic-related air pollutants
MONDAY, Aug. 26, 2024 (HealthDay News) — Multidimensional structural racism is associated with elevated cancer risk from traffic-related air pollutants, according to a study published online Aug. 26 in Cancer.
Emily B. White, M.P.H., and Christine C. Ekenga, Ph.D., M.P.H., from Emory University in Atlanta, examined the relationship between structural racism and estimated cancer risk from air pollutants in Georgia using a multidimensional measure of structural racism, including county‐level data on residential segregation, education, employment, incarceration, economic status, political participation, and home ownership.
The researchers observed a significant association between multidimensional structural racism and exposure to carcinogenic traffic-related air pollutants in multilevel analyses. Compared with neighborhoods with lower levels of structural racism, those in the highest quartile of structural racism exhibited an elevated cancer risk from traffic-related air pollutants (relative risk, 7.84).
“By highlighting the link between structural inequalities and environmental health risks, our study underscores the importance of addressing social and systemic issues to improve public health outcomes,” Ekenga said in a statement. “This study can inform policymakers about the need for targeted interventions to reduce exposure to traffic-related air pollutants.”
Abstract/Full Text (subscription or payment may be required)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers
Air Pollution Does Not Impair Benefits of Walking in Reducing COPD Exacerbation Rate
Personalized Support Boosts Families" Genetic Testing for Hereditary Cancers
Pre-Prostate Biopsy MRI Use Increased From 2017 to 2026
Urine Cell-Free RNA Shows Promise as Biomarker for Bladder Cancer
PET/MRI Offers Diagnostic, Prognostic Value in Pediatric Epilepsy
Higher Intake of Saturated, Animal Fats May Increase Mortality in Prostate Cancer
Adverse Pathological Features Do Not Predict Benefit of Hormone Therapy in Prostate Cancer